RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.

Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.

Updates are delayed or unverified. Check original sources for the latest information.

Your saved research and appointment questions

View recorded trial and retraction changes

ICD D43.2ORPHA:251636

Ependymoma

Ependymoma is a rare tumour that arises from ependymal cells, which line the fluid-filled spaces of the brain and spinal cord. It can occur in children and adults, and symptoms depend on where it grows. Treatment usually involves surgery to remove as much of the tumour as possible, sometimes followed by radiotherapy. Researchers are studying molecular subtypes to guide care.

This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.

459
Articles
151
Trials (10 AU)
Data refreshed
20 October 2026
Loading...

Common Questions

What is Ependymoma?

Ependymoma is a rare tumour that arises from ependymal cells, which line the fluid-filled spaces of the brain and spinal cord. It can occur in children and adults, and symptoms depend on where it grows. Treatment usually involves surgery to remove as much of the tumour as possible, sometimes followed by radiotherapy. Researchers are studying molecular subtypes to guide care.

How many clinical trials are available for Ependymoma?

RareWays currently indexes 151 clinical trials for Ependymoma, of which 22 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.

Where does the research data for Ependymoma come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Ependymoma.

Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.